Psilocybin as a New Breakthrough Treatment for Cluster Headaches with Dr. Emmanuelle Schindler MD, PhD — The Psychedelic Report
The Psychedelic Report

Psilocybin as a New Breakthrough Treatment for Cluster Headaches with Dr. Emmanuelle Schindler MD, PhD

August 21, 2023 · 44 min

Why listen

Cluster headaches strike multiple times a day and psilocybin may be the first real relief sufferers have found.

The Psychedelic Report · Ready to play
Psilocybin as a New Breakthrough Treatment for Cluster Headaches with Dr. Emmanuelle Schindler MD, PhD
0:00––:––

Enjoy the episode?

Subscribe to The Psychedelic Report

In this episode

  • What cluster headaches actually feel like and why they are so hard to treat
  • How psilocybin works as a potential treatment for this condition
  • What the clinical research from Yale shows about safety and effectiveness
  • Why a psychedelic compound is being taken seriously by mainstream medicine

About this episode

Have you ever heard of a headache so agonizing that it's been nicknamed the "suicide headache"? Imagine experiencing excruciating pain, primarily on one side of your head, accompanied by tearing, nasal congestion, and drooping eyelids. Now, imagine enduring this torment multiple times a day, each episode lasting anywhere from 15 minutes to several hours. It's not just a nightmare scenario; it's a reality for those who suffer from cluster headaches. Join Dr. Dave Rabin MD, PhD as he sits down with Dr. Emmanuelle Schindler MD, PhD, a physician-scientist from Yale University, to take us on a journey to explore the fascinating potential of psilocybin as a promising solution that might seem surprising, but it actually works for many sufferers of this extremely challenging disorder. Help is on the way!

Learn more about your ad choices. Visit megaphone.fm/adchoices

The Psychedelic Report

About The Psychedelic Report

Dr. Dave Rabin

Dr. Dave Rabin MD, PhD, a psychiatrist and neuroscientist trained in Ketamine and MDMA-assisted therapy, brings you the newest developments from the world of psychedelic science and technology. From researchers and investors to physicians and shamans to nonprofit pioneers and policy-makers — each week, Dr.

See all episodes →